skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Cardiovascular complications of COVID-19

Hong Kong medical journal = Xianggang yi xue za zhi, 2022-06, Vol.28 (3), p.249-256 [Peer Reviewed Journal]

2022. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1024-2708 ;EISSN: 2226-8707 ;DOI: 10.12809/hkmj209217 ;PMID: 35638457

Full text available

Citations Cited by
  • Title:
    Cardiovascular complications of COVID-19
  • Author: Lo, Y S A ; Jok, C ; Tse, H F
  • Subjects: Cardiovascular disease ; Coronaviruses ; COVID-19 ; Fatalities ; Medical imaging ; Mortality
  • Is Part Of: Hong Kong medical journal = Xianggang yi xue za zhi, 2022-06, Vol.28 (3), p.249-256
  • Description: Cardiac injury associated with coronavirus disease 2019 (COVID-19) is associated with high fatality rates. We reviewed the literature on COVID-19-related cardiovascular complications to elucidate the putative causes, diagnosis, and management of cardiovascular complications of COVID-19. Putative causes of these cardiovascular complications include cytokine storm, myocarditis, coronary plaque rupture, hypercoagulability, stress cardiomyopathy or combinations thereof. Cardiac troponin, D-dimer, and N-terminal pro B-type natriuretic peptide levels all provide prognostic information on COVID-19-related cardiovascular complications: elevated levels correlate with poorer prognosis. Coronary thrombosis due to COVID-19 may be associated with a higher thrombus burden than that from other causes. Hypercoagulability can be extremely challenging to treat, and in the absence of contra-indications, thromboprophylaxis is generally indicated in intensive care unit patients. With the exception of percutaneous coronary intervention for acute myocardial infarction, there are no specific treatments for COVID-19-related cardiovascular complications and management is primarily supportive. Whether antiviral therapies, coupled with monoclonal antibodies administered early in the course of COVID-19 illness will prevent severe cardiovascular complications remains to be seen.
  • Publisher: China: Hong Kong Academy of Medicine
  • Language: English;Chinese
  • Identifier: ISSN: 1024-2708
    EISSN: 2226-8707
    DOI: 10.12809/hkmj209217
    PMID: 35638457
  • Source: DOAJ : Directory of Open Access Journals
    Freely Accessible Journals
    Coronavirus Research Database
    ProQuest Central
Back to results list
Go to Previous pagePrevious Result  7 NextGo to Next page
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait